Overview
Pilgrim's Pride Corporation, based in the United States, operates within the food industry, primarily focusing on the processing and production of poultry. As one of the largest chicken producers in the world, the company supplies a broad array of poultry products to both retail and foodservice outlets globally. Key initiatives by Pilgrim's Pride include significant investments in sustainability and animal welfare. The company has undertaken projects aimed at reducing its environmental impact and improving operational efficiencies across its facilities. These efforts are aligned with broader industry trends towards sustainability and ethical sourcing. Additionally, Pilgrim's Pride actively expands its product range to meet diverse consumer demands, incorporating organic and antibiotic-free chicken products into its portfolio.
Basic Stats
The share price of Pilgrim's Pride Corporation as of September 5, 2025 is $44.29 / share. This is a decrease of -0.36% from the prior week. The market cap (or net worth) of Pilgrim's Pride Corporation as of September 5, 2025 is $10,513.60 MM.
The Factor Analysis chart (below right) shows a view of Pilgrim's Pride Corporation from a variety of lenses. Each factor shows how well the company ranks against all other companies in the Fintel global investing universe. Factor scores range from zero to 100, with 100 being most desirable, and 50 being average.
For example, a company with a Value Score of 100 would be the most undervalued company in our database. A company with a Value Score of zero would be the most overvalued.
| Market Cap | 10,513.60 MM |
| EV | 12,794.52 MM |
| Shares Out. | 237.38 MM |
| Earnings Date | |
| EPS (TTM) | 5.21 |
| Dividend Yield | 18.97 % |
| Ex-Dividend Date | 2025-08-20 |
| Borrow Rate | 0.25 |
| Short Shares Avail. | 0.95 MM |
| Short Interest | 8.81 MM |
| Short Float | 21.06 % |
| Days to Cover | 6.73 days |
| Risk Free Rate | 4.17 % |
| Price Change (1 yr) | -2.62 % |
| Volatility (1 yr) | 0.36 |
| Beta | 0.18 |
| Sharpe Ratio (1 yr) | -0.19 |
| Sortino Ratio (1 yr) | -0.27 |
| PE Ratio | 8.50 |
| Price/Book | 2.80 |
| Price/TBV | 6.88 |
| Book/Market | 0.36 |
| EBIT/EV | 0.13 |
| EBIT(3yr avg)/EV | 0.07 |
| ROA | 0.12 |
| ROE | 0.33 |
| ROIC | 0.17 |
| CROIC | -0.07 |
| OCROIC | 0.23 |
| Implied Volatility | 30.10 % |
| Put/Call OI Ratio | 0.48 |
Factor Scores range from 0 to 100, with 100 being most desirable. Larger circles are better. In situations where we have no data (e.g. no insider trades), we plot the score at 50 to avoid penalizing companies. However, a company that does not pay dividends will get a Dividend Score of Zero. Additionally, we inverted volatility to create a "stability" metric which is better when higher.
Price Target
The average one-year price target for Pilgrim's Pride Corporation is $49.99. The forecasts range from a low of $42.53 to a high of $59.85. A stock’s price target is the price at which analysts consider it fairly valued with respect to its projected earnings and historical earnings. Analysts typically set price targets that correspond to their buy or sell recommendations.
Update Frequency: Monthly
Stock Upgrades/Downgrades
This card shows analyst upgrades/downgrades for Pilgrim's Pride Corporation. An analyst rating is a classification that gives investors a sense of analyst sentiment about the direction and performance of an equity - usually a stock - over a period of time, typically 12 months.
The standard analyst ratings are generally as follows:
- Buy/Overweight/Outperform - Any of these ratings conveys an analyst’s belief that the stock is likely to outperform a market index (e.g. the S&P 500).
- Hold/Equal-Weight/Market Perform - Any of these ratings conveys an analyst’s belief that the stock is likely to perform in line with a market index.
- Sell/Underweight/Underperform - Any of these ratings suggest that an analyst believes the stock is likely to underperform a market index.
When an analyst upgrades a stock, they are signaling that the company’s fundamentals are being undervalued by investors. It could also mean they believe the market is underestimating the company’s potential. The opposite is true when a stock receives a downgrade.
The average rating of each individual analyst’s rating is the consensus rating for a stock. This gives investors a broader sense of the overall sentiment for that stock.
| Date | Analyst | Prior | Latest Recommendation |
Action |
|---|---|---|---|---|
| 2022-10-25 | Barclays | Overweight | Maintains | |
| 2022-10-18 | Goldman Sachs | Neutral | Maintains | |
| 2022-07-29 | Barclays | Overweight | Maintains | |
| 2022-03-15 | Barclays | Overweight | Reiterate | |
| 2020-03-31 | Barclays | Overweight | Maintains | |
| 2014-06-06 | BB&T Capital | Buy | Hold | Downgrade |
| 2014-03-14 | Stephens & Co. | Equal-Weight | Overweight | Upgrade |
| 2014-02-24 | BB&T Capital | Hold | Buy | Upgrade |
| 2013-08-15 | Stephens & Co. | Overweight | Equal-Weight | Downgrade |
| 2013-02-19 | BMO Capital | Market Perform | Maintains | |
| 2012-11-30 | Stephens & Co. | Equal-Weight | Overweight | Upgrade |
| 2012-11-13 | Imperial Capital | In-Line | Maintains | |
| 2012-10-29 | BMO Capital | Market Perform | Maintains | |
| 2012-10-29 | B. Riley FBR | Neutral | Buy | Upgrade |
| 2012-08-22 | S&P Capital IQ | Developing | Negative | Downgrade |
| 2012-08-10 | Imperial Capital | Outperform | In-Line | Downgrade |
| 2012-07-30 | BMO Capital | Market Perform | Maintains | |
| 2012-07-09 | B. Riley FBR | Buy | Neutral | Downgrade |
| 2022-03-10 | BMO Capital | Market Perform | Outperform | Upgrade |
| 2022-02-18 | Stephens & Co. | Equal-Weight | Overweight | Upgrade |
| 2021-06-03 | Barclays | Overweight | Maintains | |
| 2021-02-08 | Stephens & Co. | Equal-Weight | Overweight | Upgrade |
| 2020-10-30 | Barclays | Equal-Weight | Overweight | Upgrade |
| 2020-06-29 | BMO Capital | Outperform | Market Perform | Downgrade |
| 2020-06-29 | Barclays | Overweight | Equal-Weight | Downgrade |
| 2020-02-24 | Stephens & Co. | Equal-Weight | Reiterate | |
| 2020-02-21 | CFRA | Strong Buy | Buy | Downgrade |
| 2020-01-16 | Stephens & Co. | Overweight | Equal-Weight | Downgrade |
| 2019-10-25 | Bank of America | Neutral | Initiate | |
| 2019-08-20 | BMO Capital | Market Perform | Outperform | Upgrade |
| 2019-08-02 | Mizuho | Buy | Maintains | |
| 2019-03-05 | Stephens & Co. | Overweight | Initiate | |
| 2018-03-29 | Mizuho | Buy | Initiate | |
| 2018-03-14 | Vertical Group | Hold | Buy | Upgrade |
| 2018-02-27 | Morgan Stanley | Equal-Weight | Equal-Weight | Maintains |
| 2017-11-10 | Morgan Stanley | Equal-Weight | Maintains | |
| 2017-11-09 | BMO Capital | Market Perform | Maintains | |
| 2017-11-03 | Morgan Stanley | Equal-Weight | Initiate | |
| 2017-04-21 | Vertical Research | Hold | Buy | Upgrade |
| 2017-03-27 | KeyBanc | Overweight | Sector Weight | Downgrade |
| 2016-12-02 | KeyBanc | Overweight | Initiate | |
| 2016-11-30 | Jefferies | Hold | Maintains | |
| 2016-10-12 | Jefferies | Hold | Maintains | |
| 2016-06-06 | BMO Capital | Outperform | Market Perform | Downgrade |
| 2016-05-25 | BB&T Capital | Buy | Hold | Downgrade |
| 2015-12-15 | Jefferies | Hold | Initiate | |
| 2015-11-04 | BB&T Capital | Hold | Buy | Upgrade |
| 2015-10-30 | BMO Capital | Market Perform | Outperform | Upgrade |
| 2015-06-12 | Cleveland Research | Neutral | Initiate | |
| 2014-10-31 | BB&T Capital | Hold | Buy | Upgrade |
| 2014-10-03 | Goldman Sachs | Hold | Initiate | |
| 2014-06-24 | Stephens & Co. | Overweight | Equal-Weight | Downgrade |
| 2023-02-09 | Stephens & Co. | Equal-Weight | Maintains | |
| 2023-04-27 | Stephens & Co. | Equal-Weight | Reiterate | |
| 2023-04-14 | BMO Capital | Market Perform | Reiterate | |
| 2023-04-28 | B of A Securities | Neutral | Buy | Upgrade |
| 2023-04-28 | Barclays | Overweight | Maintains | |
| 2023-06-01 | Barclays | Overweight | Overweight | Maintains |
| 2023-07-13 | BMO Capital | Market Perform | Outperform | Upgrade |
| 2024-04-16 | Barclays | Overweight | Equal-Weight | Downgrade |
| 2024-04-15 | B of A Securities | Buy | Buy | Maintains |
| 2024-02-27 | Goldman Sachs | Neutral | Neutral | Maintains |
| 2024-02-27 | BMO Capital | Outperform | Outperform | Maintains |
| 2024-02-27 | Barclays | Overweight | Overweight | Maintains |
| 2024-04-17 | Goldman Sachs | Neutral | Neutral | Maintains |
| 2024-07-10 | B of A Securities | Buy | Buy | Maintains |
| 2024-06-18 | Argus Research | Buy | Initiate | |
| 2024-08-28 | Argus Research | Buy | Buy | Maintains |
| 2024-10-03 | Stephens & Co. | Equal-Weight | Reiterate | |
| 2024-08-15 | B of A Securities | Buy | Neutral | Downgrade |
| 2024-07-25 | Barclays | Equal-Weight | Equal-Weight | Maintains |
| 2024-11-01 | BMO Capital | Market Perform | Market Perform | Maintains |
| 2024-11-01 | Barclays | Equal-Weight | Equal-Weight | Maintains |
| 2024-08-02 | Barclays | Equal-Weight | Equal-Weight | Maintains |
| 2024-08-02 | BMO Capital | Outperform | Outperform | Maintains |
| 2024-07-23 | Argus Research | Buy | Buy | Maintains |
| 2024-08-12 | BMO Capital | Outperform | Market Perform | Downgrade |
| 2025-03-17 | BMO Capital | Market Perform | Market Perform | Maintains |
| 2024-09-09 | Barclays | Equal-Weight | Equal-Weight | Maintains |
| 2025-06-23 | Goldman Sachs | Neutral | Initiate |
